Xenon Pharmaceuticals Announces Closing Of Initial Public Offering And Full Exercise Of The Underwriters' Option To Purchase Additional Shares

By: via Benzinga
Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a clinical-stage biopharmaceutical company, today announced the closing of its previously ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.